Genesys III raises most of $125 mln target from HarbourVest, other LPs

Aug 16, 2016 - TORNTO - Genesys Capital has collected almost three-quarters of the $125 million target set for its third venture fund, adding to the momentum felt of late in Canada’s life-sciences sector.

Genesys Ventures III initially closed at $90 million in committed capital, the Toronto firm said today. It is expected to reach its goal early next year, Managing Director Damian Lamb told PE Hub Canada. 

Should the fund reach its $125 million target, it will be the largest Genesys has raised in its 16-year history.

For the full article, click here

Previous
Previous

CAAP Company: Eve Medical Wins "The Next 36" Alumni Achievement Award

Next
Next

CAAP & Pre-CAAP Companies: Medella Health, Shift Health, and NERv TEchnology Chosen as Top 10 Finalists in the 2016 INTERFACE Health Challenge X